Gametocyte dynamics and the role of drugs in reducing the transmission potential of Plasmodium vivax.

Gametocyte dynamics and the role of drugs in reducing the transmission potential of Plasmodium vivax.

BACKGROUND: Designing interventions that will reduce transmission of vivax malaria requires knowledge of Plasmodium vivax gametocyte dynamics. METHODS: We analyzed data from a randomized controlled trial in northwestern Thailand and 2 trials in Papua, Indonesia, to identify and compare risk factors...

Full description

Bibliographic Details
Main Authors:	Douglas, N, Simpson, J, Phyo, A, Siswantoro, H, Hasugian, A, Kenangalem, E, Poespoprodjo, JR, Singhasivanon, P, Anstey, N, White, N, Tjitra, E, Nosten, F, Price, R
Format:	Journal article
Language:	English
Published:	Oxford University Press 2013

Similar Items

Plasmodium vivax infection: a major determinant of severe anaemia in infancy
by: Kenangalem, E, et al.
Published: (2017)

The anaemia of Plasmodium vivax malaria.
by: Douglas, N, et al.
Published: (2012)

Plasmodium vivax: clinical spectrum, risk factors and pathogenesis.
by: Anstey, N, et al.
Published: (2012)

Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic.
by: Poespoprodjo, JR, et al.
Published: (2008)

In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.
by: Hasugian, A, et al.
Published: (2009)

Transmission-blocking activities of artesunate, chloroquine, and methylene blue on Plasmodium vivax gametocytes
by: Chaumeau, V, et al.
Published: (2024)

Seasonal fluctuations in the carriage of Plasmodium vivax gametocytes in Thailand.
by: Nacher, M, et al.
Published: (2004)

In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.
by: Price, R, et al.
Published: (2010)

Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.
by: Hasugian, A, et al.
Published: (2007)

Alternative treatment options for chloroquine resistant Plasmodium vivax in Papua, Indonesia
by: Price, R, et al.
Published: (2005)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
by: Setyadi, A, et al.
Published: (2019)

Artemisinin-napthoquine versus dihydroartemisinin-piperaquine in adult subjects with Plasmodium vivax infection
by: Armedy Ronny Hasugian, et al.
Published: (2016-03-01)

Artemisinin-napthoquine versus dihydroartemisinin-piperaquine in adult subjects with Plasmodium vivax infection
by: Armedy Ronny Hasugian, et al.
Published: (2016-03-01)

High risk of Plasmodium vivax malaria following splenectomy in Papua, Indonesia
by: Kho, S, et al.
Published: (2018)

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy
by: Poespoprodjo, JR, et al.
Published: (2014)

Plasmodium vivax infection: A major determinant of severe anaemia in Papua, Indonesia
by: Price, R, et al.
Published: (2007)

Coma associated with microscopy-diagnosed Plasmodium vivax: a prospective study in Papua, Indonesia
by: Lampah, D, et al.
Published: (2011)

Treatment seeking behavior of patients with Plasmodium falciparum or P-vivax infection in Papua, Indonesia
by: Karyana, M, et al.
Published: (2007)

Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia.
by: Ratcliff, A, et al.
Published: (2007)

Severe disease associated with both Plasmodium falciparum and P-vivax infection in Papua, Indonesia
by: Tjitra, E, et al.
Published: (2007)

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
by: Thriemer, K, et al.
Published: (2020)

Effects of different antimalarial drugs on gametocyte carriage in P. vivax malaria.
by: Pukrittayakamee, S, et al.
Published: (2008)

Chemotherapeutic strategies for reducing transmission of Plasmodium vivax malaria.
by: Douglas, N, et al.
Published: (2012)

Vivax malaria: a major cause of morbidity in early infancy.
by: Poespoprodjo, JR, et al.
Published: (2009)

Naturally acquired antibodies to gametocyte antigens are associated with reduced transmission of Plasmodium vivax gametocytes to Anopheles arabiensis mosquitoes
by: Surafel K. Tebeje, et al.
Published: (2023-01-01)

Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia.
by: Douglas, N, et al.
Published: (2014)

Plasmodium vivax relapse rates following plasmodium falciparum malaria reflect previous transmission intensity
by: Ashley, E, et al.
Published: (2019)

Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study
by: Douglas, NM, et al.
Published: (2017)

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: A prospective study in Papua, Indonesia
by: Tjitra, E, et al.
Published: (2008)

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia.
by: Tjitra, E, et al.
Published: (2008)

MULTIDRUG RESISTANT VIVAX MALARIA: A MAJOR CAUSE OF MORBIDITY IN EARLY LIFE
by: Poespoprodjo, JR, et al.
Published: (2008)

Differential cellular recognition of antigens during acute Plasmodium falciparum and Plasmodium vivax malaria.
by: Salwati, E, et al.
Published: (2011)

Identification of the asymptomatic Plasmodium falciparum and Plasmodium vivax gametocyte reservoir under different transmission intensities.
by: Cristian Koepfli, et al.
Published: (2021-08-01)

Greater endothelial activation, Weibel-Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: a prospective study in Papua, Indonesia.
by: Yeo, T, et al.
Published: (2010)

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia.
by: Kamala Thriemer, et al.
Published: (2020-11-01)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
by: Agus Setyadi, et al.
Published: (2019-04-01)

In vitro and molecular characterisation of multidrug resistant Plasmodium vivax.
by: Suwanarusk, R, et al.
Published: (2008)

Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax.
by: Suwanarusk, R, et al.
Published: (2008)

Determinants of in vitro drug susceptibility testing of Plasmodium vivax.
by: Russell, B, et al.
Published: (2008)

Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.
by: Phyo, A, et al.
Published: (2011)